Mode
Text Size
Log in / Sign up
Phase 2 Completed N=43 Randomized Double-blind Treatment

A Remotely Delivered Episodic Future Thinking Intervention to Improve Management of Type 2 Diabetes

Source: ClinicalTrials.gov NCT03732209 ↗
Enrolled (actual)
43
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcomePrimary: Change in Glycosylated Hemoglobin — -1.2; -0.30; -1.4; -0.5 percentage of glycosylated hemoglobin — p=.017

Summary

The goals of this project are to assess the efficacy of remotely delivered episodic future thinking for reducing delay discounting and improving management of type 2 diabetes, including glycemic control, weight loss, medication adherence, dietary intake, physical activity, and blood pressure. This will be accomplished by randomly assigning participants (N = 64) to episodic future thinking or control thinking groups, while tracking outcome measures before, during, and after the 4-month intervention, as well at a 6-month follow-up visit. Participants in both groups will also receive access to an information-based weight loss intervention.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Glycosylated Hemoglobin
-1.2; -0.30; -1.4; -0.5; -3.3; -1 .017 sig
PRIMARY
Change in kg/m^2 (Body Mass Index)
-1.2; -0.3; -1.4; 0.71; -0.7; 0.1 .042 sig
PRIMARY
Change in Delay Discounting Area Under the Curve (Normalized)
0.07; -0.04; 0.07; 0.02; 0.15; -0.07 .146
SECONDARY
Perceived Treatment Effectiveness
3.63; 2.4; 3.5; 3; 3; 3.75 .042 sig

Eligibility Criteria

Inclusion Criteria

  • Overweight or obese (BMI of 25 or greater)
  • Poorly controlled type 2 diabetes (HbA1C of 8% or greater)
  • Prescribed or recommended oral glucose-lowering medication

Exclusion Criteria

  • Current insulin therapy for type 2 diabetes
  • History of gestational diabetes
  • Pregnant or lactating
  • Not ambulatory
  • Intellectual impairment
  • Unmanaged medical or psychiatric disorder
  • Abnormal glucose related to medications (e.g, glucocorticoids)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03732209). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search